V-Bio Ventures
Investor profile
Venture capital
V-Bio Ventures has backed 7 European tech companies across 7 funding rounds between 2018 and 2022, joining rounds totalling €222M. Most active in Healthtech and Agritech. Data as of Nov 2026.
Deals
7
distinct rounds
Companies
7
backed
Active span
2018–2022
5 yrs
Total round €
€222M
sum of rounds joined
Deals by year
distinct rounds / yearV-Bio Ventures — deals by year — interactive chart.
Data table
| V-Bio Ventures — deals by year | |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 4 |
Top sectors
by dealsV-Bio Ventures — top sectors — interactive chart.
Data table
| V-Bio Ventures — top sectors | |
|---|---|
| Healthtech | 6 |
| Agritech | 1 |
Stages
by dealsV-Bio Ventures — stages — interactive chart.
Data table
| V-Bio Ventures — stages | |
|---|---|
| Series A | 4 |
| Series B | 2 |
| Seed | 1 |
Countries
by dealsV-Bio Ventures — countries — interactive chart.
Data table
| V-Bio Ventures — countries | |
|---|---|
| Belgium | 5 |
| France | 1 |
| Italy | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- FundPlus2
- GIMV2
- Seroba Life Sciences2
- 3B Future Health Fund1
- Ackermans & van Haaren1
- Advent France Biotechnology1
- AIF1
- BioMedPartners1
- BNP Paribas Fortis Private Equity1
- CDP Venture Capital1
- Claris Ventures1
- eureKARE1
- Evolution Ventures1
- Flanders Future Techfund (FFTF)1
- Forbion1
- Go Capital1
- HealthCap1
- IDInvest Partners1
- Indaco Venture Partners1
- INKEF Capital1
- Jeito Capital1
- KU Leuven Gemma Frisius Fund1
- Kurma Partners1
- Mérieux Equity Partners1
- Novo Holdings1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Precirix | Belgium | 1 | €80M |
| Camel-IDS | Belgium | 1 | €37M |
| AstriVax | Belgium | 1 | €30M |
| Sibylla Biotech | Italy | 1 | €23M |
| Coave Therapeutics | France | 1 | €21M |
| Agomab Therapeutics | Belgium | 1 | €21M |
| Animab | Belgium | 1 | €10M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Precirix | Series B | €80M | 2022-03 |
| Camel-IDS | Series A | €37M | 2018-11 |
| AstriVax | Seed | €30M | 2022-08 |
| Sibylla Biotech | Series A | €23M | 2022-10 |
| Coave Therapeutics | Series B | €21M | 2021-07 |
| Agomab Therapeutics | Series A | €21M | 2019-04 |
| Animab | Series A | €10M | 2022-11 |